FDA Enforcement Class II Terminated

LumiraDx SARS-CoV-2 Ag Test Strip Kit US EUA (48 Tests / EN). LumiraDx Severe Acute Respiratory Syndrome (SARS) CoV-2 Antigen (Ag) Test Strips, Catalog #:L016000109048. Part of the LumiraDx Platform, a point of care system for professional use for in vitro diagnostic tests. It comprises a portable LumiraDx Instrument and a LumiraDx Test Strip for the required test.

Recall: Z-1132-2021 · Reported February 24, 2021

Enforcement

Recall Number
Z-1132-2021
Event ID
87259
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
LumiraDx
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
February 24, 2021
Initiation Date
January 11, 2021
Classification Date
February 17, 2021
Termination Date
December 3, 2021
Address
221 Crescent St, N/A, Waltham, MA, 02453-3475, United States

Description

LumiraDx SARS-CoV-2 Ag Test Strip Kit US EUA (48 Tests / EN). LumiraDx Severe Acute Respiratory Syndrome (SARS) CoV-2 Antigen (Ag) Test Strips, Catalog #:L016000109048. Part of the LumiraDx Platform, a point of care system for professional use for in vitro diagnostic tests. It comprises a portable LumiraDx Instrument and a LumiraDx Test Strip for the required test.

Reason

Observations of potential false positive results in the specified lots. Use of these test strips may result in false positive patient test results and potential exposure to unnecessary treatment or quarantine.

Code Info

Catalog #:L016000109048 Lot #: 5000269 (GM2000238), 5000280 (GM2000232), 5000306 (GM2000261) (Updated 3/15/2021) 5000323 (GM2000354), 6000142 (GM2000296), 6000100 (GM2000322)

Distribution

Worldwide distribution. US states of CA, GA, PA, SD. (Updated 3/15/2021) Austria, Germany, Ireland, Italy, Lebanon, Netherlands, Slovenia, Spain, United Kingdom.

Quantity

3,274,272 strips (Updated 3/15/2021 added 69,168 strips)